tri agonist glp 1 LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor for glycemic control and weight loss: From discovery to clinical proof of concept: Cell Metabolism Why target one pathway when

What can be done to mitigate the effects of muscle loss during GLP-1 treatment

In: Post T, ed

Its primary role is to help regulate blood sugar and appetite, making it a key player in metabolic health and weight regulation

She cautioned that the GLP-1 drugs dont work the same way for all users and that they have risks that must be weighed against potential benefits

Unequivocally, we do not see the same effects in humans as we do in rodents, says Elizabeth Pearce, MD, an endocrinologist and thyroid specialist at Boston Medical Center

Effective counselling on injection technique, dose titration and adverse effects can improve adherence to this therapeutic class